Two high-frequency-transduction phage isolates from lysogenic strains of Pseudomonas aeruginosa transducing antibiotic resistance. 1998

J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
Institute of Preventive and Clinical Medicine, Limbová, Bratislava, Slovak Republic.

Two high frequency transduction (HFT) phage isolates, obtained from seriously ill patients, transducing individual determinants of antibiotic resistance with a frequency of 10(-5) (phage isolate AP-103) and 10(-6) (phage isolate AP-343), are described. The frequency of transduction depended on the transduced determinant(s) of resistance used for the detection of transductants and on the individual recipient antibiotic-susceptible strain of Pseudomonas aeruginosa (PAO and/or ML series). A multiple-antibiotic resistance was transduced by the phage isolate AP-343 to all tested recipient strains. The appearance of such phages in clinical conditions with an unusually high frequency of transduction might contribute to the dissemination of antibiotic resistance genes among nosocomial strains of P. aeruginosa. The existence of HFT phages might reflect an increased efficiency of transduction of antibiotic resistance among P. aeruginosa strains, and thus an increased risk of spread of antibiotic resistance even to recently introduced anti-pseudomonadal antibiotics among pseudomonads with unfavourable and unwanted epidemiological consequences in hospital conditions.

UI MeSH Term Description Entries
D008242 Lysogeny The phenomenon by which a temperate phage incorporates itself into the DNA of a bacterial host, establishing a kind of symbiotic relation between PROPHAGE and bacterium which results in the perpetuation of the prophage in all the descendants of the bacterium. Upon induction (VIRUS ACTIVATION) by various agents, such as ultraviolet radiation, the phage is released, which then becomes virulent and lyses the bacterium. Integration, Prophage,Prophage Integration,Integrations, Prophage,Prophage Integrations
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014161 Transduction, Genetic The transfer of bacterial DNA by phages from an infected bacterium to another bacterium. This also refers to the transfer of genes into eukaryotic cells by viruses. This naturally occurring process is routinely employed as a GENE TRANSFER TECHNIQUE. Genetic Transduction,Genetic Transductions,Transductions, Genetic
D017105 Pseudomonas Phages Viruses whose host is Pseudomonas. A frequently encountered Pseudomonas phage is BACTERIOPHAGE PHI 6. Pseudomonas Bacteriophages,Bacteriophage, Pseudomonas,Bacteriophages, Pseudomonas,Pseudomonas Bacteriophage,Pseudomonas Phage
D018432 Drug Resistance, Multiple Simultaneous resistance to several structurally and functionally distinct drugs. Drug Resistance, Extensively,Extensively Drug Resistance,Extensively-Drug Resistance,Multidrug Resistance,Multi-Drug Resistance,Extensively Drug Resistances,Extensively-Drug Resistances,Multiple Drug Resistance,Resistance, Extensively Drug,Resistance, Extensively-Drug,Resistance, Multiple Drug

Related Publications

J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
June 1994, Journal of chemotherapy (Florence, Italy),
J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
January 2003, Bacteriologia, virusologia, parazitologia, epidemiologia (Bucharest, Romania : 1990),
J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
January 2023, Frontiers in cellular and infection microbiology,
J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
April 1994, Molecular ecology,
J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
January 1957, Acta microbiologica Academiae Scientiarum Hungaricae,
J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
January 1980, Genetika,
J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
January 2024, Frontiers in cellular and infection microbiology,
J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
January 1979, Antibiotiki,
J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
May 2004, Journal of bacteriology,
J Blahová, and K Králiková, and V Krcméry, and A Mikovicová, and N Bartoníková
December 2021, Burns : journal of the International Society for Burn Injuries,
Copied contents to your clipboard!